Position history for Bank Julius Baer & Co. Ltd, Zurich's holdings in ABBOTT LABORATORIES
Bank Julius Baer & Co. Ltd, Zurich holds 2.6M shares of ABT (ABBOTT LABORATORIES), worth $263.7M as of 2026-Q1. The position was increased (+1.0% shares). ABT represents 0.8% of Bank Julius Baer & Co. Ltd, Zurich's portfolio.
Current Value
$263.7M
Current Shares
2.6M
Total Value Change
+$137.1M
Total Shares Change
+1.5M
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.6M |
+1.0% |
| $263.7M |
| 0.8% |
| $113.61 |
44 |
| 2025-Q4 | Increased | 2.5M | +77.8% | $319.1M | 0.9% | $125.15 | 66 |
| 2025-Q3 | Increased | 1.4M | +2.7% | $191.8M | 0.5% | $131.85 | 44 |
| 2025-Q2 | Increased | 1.4M | +9.1% | $189.6M | 0.6% | $132.52 | 47 |
| 2025-Q1 | Increased | 1.3M | +16.7% | $169.4M | 0.6% | $128.41 | 50 |
| 2024-Q4 | Increased | 1.1M | +5.5% | $133.7M | 0.4% | $110.14 | 38 |
| 2024-Q3 | Decreased | 1M | -6.3% | $135.9M | 0.5% | $109.27 | 0 |
| 2024-Q2 | Decreased | 1.1M | -13.1% | $126.6M | 0.5% | $100.45 | 0 |